Patents/Inventors

Daniel L. Flynn

Waltham, MAUS22 patents

16 Patents

US126166832026
Combination Therapy for the Treatment of Gastrointestinal Stromal Tumors
Deciphera Pharmaceuticals, LLC
0 cites
US125826552026
Methods of Treating Disorders Using CSFIR Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US125772492026
GCN2 and Perk Kinase Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US124851202025
Methods of Treating Disorders Using CSF1R Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US124798332025
Heteroarylaminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US124149552025
Anti-viral Activity of VPS34 Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US123770972025
Aminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US123196552025
RAF Kinase Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US122854302025
Methods of Treating Disorders Using CSF1R Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US121026202024
Combination Therapy for the Treatment of Mastocytosis
Deciphera Pharmaceuticals, LLC
0 cites
US120714322024
Phenylaminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US119864632024
Combination Therapy for the Treatment of Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, LLC
0 cites
US119126682024
GCN2 and Perk Kinase Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites
US118012382023
Anti-viral Activity of VPS34 Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US116791102023
Methods of Treating Disorders Using CSF1R Inhibitors
Deciphera Pharmaceuticals, LLC
0 cites
US115901342023
Aminopyrimidine Amide Autophagy Inhibitors and Methods of Use Thereof
Deciphera Pharmaceuticals, LLC
0 cites